During the past decade, Centre Henri Becquerel conducted 188 clinical trials. In the 10-year time frame, 188 clinical trials started and 35 clinical trials were completed, i.e. on average, 18.6% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 17 clinical trials were completed. i.e. 26.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Henri Becquerel" #1 sponsor was "UNICANCER" with 44 trials, followed by "The Lymphoma Academic Research Organisation" with 37 trials sponsored, "Centre Henri Becquerel" with 36 trials sponsored, "Groupe Francophone des Myelodysplasies" with 29 trials sponsored and "Centre Francois Baclesse" with 29 trials sponsored. Other sponsors include 240 different institutions and companies that sponsored additional 102 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Henri Becquerel" #1 collaborator was "National Cancer Institute, France" with 14 trials as a collaborator, "Roche Pharma AG" with 11 trials as a collaborator, "AstraZeneca" with 9 trials as a collaborator, "Pfizer" with 8 trials as a collaborator and "Amgen" with 7 trials as a collaborator. Other collaborators include 277 different institutions and companies that were collaborators in the rest 180 trials.

According to Clinical.Site data, the most researched conditions in "Centre Henri Becquerel" are "Breast Cancer" (42 trials), "Myelodysplastic Syndromes" (22 trials), "Chronic Lymphocytic Leukemia" (14 trials), "Lymphoma" (14 trials) and "Multiple Myeloma" (14 trials). Many other conditions were trialed in "Centre Henri Becquerel" in a lesser frequency.

Most popular intervention types in "Centre Henri Becquerel" are "Drug" (284 trials), "Other" (63 trials), "Procedure" (45 trials), "Radiation" (36 trials) and "Biological" (25 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (28 trials), "Lenalidomide" (18 trials), "Placebo" (17 trials), "cyclophosphamide" (14 trials) and "Cyclophosphamide" (10 trials). Other intervention names were less common.

The vast majority of trials in "Centre Henri Becquerel" are 322 trials for "All" genders, 80 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 145 active trials in "Centre Henri Becquerel". 3 are not yet recruiting, 82 are recruiting, 59 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 198 completed trials in Centre Henri Becquerel, 1 suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Henri Becquerel, 39 "Phase 1" clinical trials were conducted, 177 "Phase 2" clinical trials and 128 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 60 trials that are defined as “Not Applicable".

Centre Henri Becquerel has several departments that took part in Clinical trials: "Centre Henri Becquerel; Hematologie" - 24 trials, "Centre Henri Becquerel; Oncologie Medicale" - 8 trials